Indian drugmaker Zydus Cadila said on Thursday it has applied for emergency use approval of its three-dose COVID-19 vaccine that showed efficacy of 66.6% in an interim study and could become the...
from NDTV News - Topstories https://ift.tt/3jAY2GL
from NDTV News - Topstories https://ift.tt/3jAY2GL